Literature DB >> 22116947

Sodium (23Na) MRI detects elevated muscular sodium concentration in Duchenne muscular dystrophy.

M-A Weber1, A M Nagel, K Jurkat-Rott, F Lehmann-Horn.   

Abstract

OBJECTIVE: In boys with Duchenne muscular dystrophy (DMD), (1)H MRI suggested muscular edema before fatty degeneration. Using specific (23)Na MRI sequences, we tested the hypothesis that the edema is caused by an osmotic effect due to increased myoplasmic Na(+) content rather than inflammation that would lead to extracellular edema.
METHODS: Eleven patients with DMD (mean age, 10 ± 5 years) and 16 healthy volunteers of similar age were examined on a 3-T system with (1)H MRI and (23)Na density-adapted 3-dimensional radial MRI sequences. The muscle edema was quantified on short-tau inversion recovery images using background noise as reference. Fatty degeneration was quantified on T1-weighted images using subcutaneous fat as reference. Na(+) was quantified by a muscular tissue sodium concentration (TSC) sequence. A novel inversion recovery (IR) sequence allowed us to determine mainly the myoplasmic Na(+) by suppression of the extracellular (23)Na signal from vasogenic edema. A reference tube containing 51.3 mmol/L Na(+) with agarose gel was used for standardization.
RESULTS: The normalized muscular signal intensity of (23)Na as assessed by the IR sequence was significantly higher for patients with DMD than for volunteers. TSC was markedly increased at 38.4 ± 6.8 mmol/L in patients with DMD compared with 25.4 ± 2.1 mmol/L in volunteers. The muscular edema-like changes were much more prominent in patients with DMD than in volunteers. In addition, the muscular fat content was significantly higher in patients with DMD than in volunteers.
CONCLUSIONS: The elevated myoplasmic Na(+) concentration in DMD is osmotically relevant and causes a mainly intracellular muscle edema that contributes to the pathogenesis of DMD.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22116947     DOI: 10.1212/WNL.0b013e31823b9c78

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  23 in total

Review 1.  MR Imaging of the Musculoskeletal System Using Ultrahigh Field (7T) MR Imaging.

Authors:  Hamza Alizai; Gregory Chang; Ravinder R Regatte
Journal:  PET Clin       Date:  2018-10

Review 2.  Quantitative techniques for musculoskeletal MRI at 7 Tesla.

Authors:  Neal K Bangerter; Meredith D Taylor; Grayson J Tarbox; Antony J Palmer; Daniel J Park
Journal:  Quant Imaging Med Surg       Date:  2016-12

Review 3.  Quantitative sodium magnetic resonance imaging of cartilage, muscle, and tendon.

Authors:  Neal K Bangerter; Grayson J Tarbox; Meredith D Taylor; Joshua D Kaggie
Journal:  Quant Imaging Med Surg       Date:  2016-12

Review 4.  Advancements in magnetic resonance imaging-based biomarkers for muscular dystrophy.

Authors:  Doris G Leung
Journal:  Muscle Nerve       Date:  2019-05-14       Impact factor: 3.217

5.  Permanent muscular sodium overload and persistent muscle edema in Duchenne muscular dystrophy: a possible contributor of progressive muscle degeneration.

Authors:  M-A Weber; A M Nagel; M B Wolf; K Jurkat-Rott; H-U Kauczor; W Semmler; F Lehmann-Horn
Journal:  J Neurol       Date:  2012-04-28       Impact factor: 4.849

6.  Sodium MRI and the assessment of irreversible tissue damage during hyper-acute stroke.

Authors:  Fernando E Boada; Yongxian Qian; Edwin Nemoto; Tudor Jovin; Charles Jungreis; S C Jones; Jonathan Weimer; Vincent Lee
Journal:  Transl Stroke Res       Date:  2012-05-04       Impact factor: 6.829

7.  Longitudinal measurements of MRI-T2 in boys with Duchenne muscular dystrophy: effects of age and disease progression.

Authors:  R J Willcocks; I A Arpan; S C Forbes; D J Lott; C R Senesac; E Senesac; J Deol; W T Triplett; C Baligand; M J Daniels; H L Sweeney; G A Walter; K Vandenborne
Journal:  Neuromuscul Disord       Date:  2014-01-11       Impact factor: 4.296

8.  Na+ dysregulation coupled with Ca2+ entry through NCX1 promotes muscular dystrophy in mice.

Authors:  Adam R Burr; Douglas P Millay; Sanjeewa A Goonasekera; Ki Ho Park; Michelle A Sargent; James Collins; Francisco Altamirano; Kenneth D Philipson; Paul D Allen; Jianjie Ma; José Rafael López; Jeffery D Molkentin
Journal:  Mol Cell Biol       Date:  2014-03-24       Impact factor: 4.272

9.  Rationale for treating oedema in Duchenne muscular dystrophy with eplerenone.

Authors:  Frank Lehmann-Horn; Marc-André Weber; Armin M Nagel; Hans-Michael Meinck; Simon Breitenbach; Johannes Scharrer; Karin Jurkat-Rott
Journal:  Acta Myol       Date:  2012-05

Review 10.  The role of fibrosis in Duchenne muscular dystrophy.

Authors:  Werner Klingler; Karin Jurkat-Rott; Frank Lehmann-Horn; Robert Schleip
Journal:  Acta Myol       Date:  2012-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.